Intracranial Stents Market – Insights
Narrowing of the blood vessels or blood clots due to building up of fats, plaque, and other substances in the blood vessels is called intracranial stenosis. This condition marks with a stroke either to the carotid artery in the neck or in an intracranial artery. Stents during this condition act as a permanent implant which allows blood flow to the brain by opening the blocked arteries. Angioplasty (use of balloon catheter) along with placement of a stent may be an appropriate treatment for the patients who have had a stroke or transient ischemic attack (TIA). However, since these stents are designed for use in the heart, it is complex to use them in the arteries of the brain. Though, with the advent of the new self-expanding brain stents, the rate of reoccurrence of artery narrowing can be lowered. For instance, Acclino microstent offered by Acandis GmbH, shows a satisfactory safety profile and a promising rate of immediate and mid-term complete aneurysm occlusion for stent-assisted coil embolization in wide-neck intracranial aneurysms.
The global intracranial stents market size was valued at US$ 313.5 million in 2017, and is expected to witness a CAGR of 15.6% over the forecast period (2018 – 2026).
Figure 1. Global Intracranial Stents Market Share Analysis (%), By Region, 2017
Source: Coherent Market Insights Analysis (2018)
Intracranial Stents Market Dynamics
Increasing incidence of stroke and brain aneurysm is propelling demand for intracranial stents. According to the Brain Aneurysm Foundation (BAF), brain aneurysm accounts for around 500,000 deaths worldwide annually. Moreover, BAF estimates that aneurysm is predominant in the age group of 35–60 years. Furthermore, high prevalence of stroke among geriatric population worldwide is also expected to propel demand for intracranial stents in the near future. According to the data published in the Medscape, 2010, around 75-89% of strokes occur in individuals aged > 65 years. Of these strokes, 50% occur in people who are aged ≥ 70 years and nearly 25% occur in individuals who are aged > 85 years.
Integration of advanced software with existing products are gaining significant traction among various market players of intracranial stents with affordable costs thus, expected to drive intracranial stents market growth. For instance, in September 2016, Medtronic plc received the U.S. Food and Drug Administration (FDA) approval for its StealthStation, which is integrated with Medtronic’s latest O-arm Imaging System, enabling clinicians to place the deep brain stimulation (DBS) leads with high level of accuracy during the cranial procedures.
However, high cost of the procedure and limited use of various intracranial stents to a small population may impact the overall market to some extent. For instance, in August 2012, the U.S. FDA approved label changes for the Wingspan Stent System offered by Stryker Corporation, reflecting changes in indications for use, and limiting the system to a much smaller group of patients between 22 and 80 years with intracranial stenosis.
Intracranial Stents Market Regional Outlook
On the basis of geography, the global intracranial stents market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to hold dominant position in this market, owing to increasing geriatric population who are more prone to brain diseases and adoption of technologically advanced products such as adoption of cranio maxillofacial implants. Emerging economies are also projected to witness significant growth in market over the forecast period, owing to high prevalence of intracranial strokes. For instance, according to the American Journal of Neuroradiology, 2011, intracranial cerebral atherosclerosis disease (ICAD) accounts for around 8%–10% of all ischemic strokes with a higher reported incidence in the Asian, African, and Hispanic descent populations. The factors responsible for disease prevalence in these regions includes cigarette smoking, hypertension, insulin-dependent diabetes mellitus, and hypercholesterolemia. Thus, emerging economies such as Asia Pacific and Latin America is likely to be the fastest growing region throughout the forecast period.
Major companies operating in the global intracranial stents market include Medtronic Plc, Balt Extrusion S.A., MicroPort Scientific Corporation, Abbott Laboratories, Stryker Corporation, Admedes Schuessler GmbH, Cardiatis, S.A, DePuy Synthes, Acandis GmbH, and Penumbra, Inc.
Intracranial stents are used for intracranial stenosis and brain aneurysms to open the blocked arteries. This procedure is relatively new for these conditions and long-term enhanced results for placement of these stents alone is still under investigation. However, various studies accepted the potential of placement of stents to reduce the risk of stroke in patients with symptomatic intracranial stenosis as compared to medical therapy alone. Thus, boosting the growth of the market over the forecast period.
Factors such as increasing prevalence of brain aneurysms and stroke, government programs to decrease the burden of traumatic brain injury, technological advancements plugging treatment gaps and availability of reimbursement are propelling demand for intracranial stents. However, high cost and stringent government regulations is negatively impacting growth of the market. Companies are therefore, adopting different strategies such as providing FDA approved on-site training, strategic collaborations, and technology upgrades in order to increase their market presence and engage with customers. For instance, in January 2018, Stryker announced the positive results of WEAVE, the post market surveillance study of the company's Wingspan stent system, for the patients suffering from intracranial atherosclerotic disease (ICAD). Thus, providing more opportunities in procedural approach with significant results.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 25 market data tables and 44 figures on "Intracranial Stents Market” - Global forecast to 2026”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.